ACSS1 Inhibitors

ACSS1 inhibitors as a chemical class primarily consist of compounds that indirectly affect the activity of ACSS1 by modulating the availability of its substrates or the utilization of its products. Since ACSS1 is crucial for converting acetate to acetyl-CoA, inhibitors in this class would generally act by either reducing the availability of acetate or altering the metabolic demand for acetyl-CoA. Compounds like hydroxycitrate and garcinia cambogia extract achieve this by inhibiting ATP citrate lyase, thus reducing the production of acetyl-CoA and decreasing the substrate availability for ACSS1. Nicotinamide, by inhibiting sirtuins, affects the post-translational modifications of proteins involved in metabolic pathways connected to ACSS1's function, possibly affecting its activity indirectly.

Other compounds such as C75 and cerulenin, known inhibitors of fatty acid synthase, may lead to an increase in acetyl-CoA levels due to the reduced synthesis of fatty acids, thereby affecting ACSS1 activity by feedback mechanisms. In contrast, compounds like etomoxir and SSO affect the utilization of acetyl-CoA in fatty acid metabolism and can thereby influence the role of ACSS1 in maintaining the acetyl-CoA pool within the cell. Berberine and metformin, through modulation of metabolic enzyme activities and activation of AMPK, can lead to wide-ranging effects on cellular metabolism that may indirectly impact ACSS1 function. Lastly, natural extracts such as those from green tea or avocado contain a complex mixture of bioactive compounds that have been found to influence lipid metabolism enzymes and, therefore, could also affect ACSS1 activity indirectly.